INVASIVE BREAST CARCINOMA

This adverse event was reported 413 times

These drugs are most commonly taken by patients reporting INVASIVE BREAST CARCINOMA:

# Drug Count
0 LETROZOLE 47
1 LETROZOLE TABLETS 42
2 RIBOCICLIB 40
3 FULVESTRANT 30
4 METHOTREXATE SODIUM 29
5 ETANERCEPT 27
6 METHOTREXATE 25
7 LEVONORGESTREL 20
8 ADALIMUMAB 19
9 PANTOPRAZOLE 19
See all common drugs associated with INVASIVE BREAST CARCINOMA

INVASIVE BREAST CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VADADUSTAT 1 0.0033
1 CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE 1 0.0023
2 TOCILIZUMAB-AAZG 1 0.0016
3 GOSERELIN 17 0.0013
4 RIBOCICLIB 40 0.0012
5 DARIFENACIN HYDROBROMIDE 1 0.0012
6 DEXRAZOXANE FOR INJECTION 1 0.0011
7 FULVESTRANT 30 0.0009
8 LETROZOLE TABLETS 42 0.0009
9 PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF 4 0.0008
See all drugs enriched for association with INVASIVE BREAST CARCINOMA